Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
Methadone Much More Effective Than Buprenorphine/naloxone for Treatment Retention, with No Difference in Mortality Risk
RESEARCH
October 21, 2024
Methadone Much More Effective Than Buprenorphine/naloxone for Treatment Retention, with No Difference in Mortality Risk

People with opioid use disorder in British Columbia who received methadone had a 37–40 per cent lower rate of treatment discontinuation compared with those who received buprenorphine/naloxone. The new research, published this…

USE OUR INTELLIGENCE October 21, 2024
Sweetened Beverage Taxes Decrease Consumption in Lower-Income Households by Nearly 50%
POLICY & LAW
October 21, 2024
Sweetened Beverage Taxes Decrease Consumption in Lower-Income Households by Nearly 50%

Eight cities in the United States have implemented taxes on sugar-sweetened beverages, which contribute to health issues including obesity and Type 2 diabetes. New research from the University of Washington investigated responses to…

USE OUR INTELLIGENCE October 21, 2024
Black Patients More Likely to Die After Coronary Bypass Surgery
DISEASES
October 21, 2024
Black Patients More Likely to Die After Coronary Bypass Surgery

Despite advances in cardiovascular medicine, Black patients are 22% more likely than white patients to die in the hospital after coronary artery bypass grafting (CABG) surgery, according to a study of more…

USE OUR INTELLIGENCE October 21, 2024
Younger Adults Respond to Colorectal Cancer Screening Outreach
DISEASES
October 21, 2024
Younger Adults Respond to Colorectal Cancer Screening Outreach

The updated national colorectal cancer screening guidelines that recommend screening begin at age 45 — rather than 50 — can benefit younger adults, a new Kaiser Permanente study found. The study, published…

USE OUR INTELLIGENCE October 21, 2024
New Gene Editing Approach Paves the Way to First-In-Human Clinical Trial for Rare Genetic Disease
PHARMA & CLINICAL TRIALS
October 16, 2024
New Gene Editing Approach Paves the Way to First-In-Human Clinical Trial for Rare Genetic Disease

A collaborative effort between investigators at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, demonstrates the…

USE OUR INTELLIGENCE October 16, 2024
High Blood Pressure Reduces Respiratory Capacity Owing to Hardening of Bronchi
DISEASES
October 16, 2024
High Blood Pressure Reduces Respiratory Capacity Owing to Hardening of Bronchi

High blood pressure (hypertension) causes thickening of the blood vessels and hardening of the arteries (arteriosclerosis). A study conducted by Brazilian researchers has shown for the first time that a similar phenomenon…

USE OUR INTELLIGENCE October 16, 2024
New Device Could Deliver Bedside Blood Test Results in an Hour
RESEARCH, TECHNOLOGY
October 16, 2024
New Device Could Deliver Bedside Blood Test Results in an Hour

Patients who go to the doctor to provide a blood sample are typically faced with a needle and syringe and hours or days of waiting to get results back from a lab. University…

USE OUR INTELLIGENCE October 16, 2024
Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health
RESEARCH
October 16, 2024
Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health

Researchers at Rutgers University-New Brunswick, along with international collaborators, have introduced a novel method for identifying the crucial set of gut microbes commonly found in humans and essential for health. The researchers,…

USE OUR INTELLIGENCE October 16, 2024
Immune Sensitivity Links Race and Survival After Prostate Cancer Immunotherapy
DISEASES
October 16, 2024
Immune Sensitivity Links Race and Survival After Prostate Cancer Immunotherapy

Duke discovery could allow targeted treatment to patients who will benefit the most Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part,…

USE OUR INTELLIGENCE October 16, 2024
Scientists Developing Microchips with Brain and Lung Tissue to Study Viral Neuroinflammation
TECHNOLOGY
October 16, 2024
Scientists Developing Microchips with Brain and Lung Tissue to Study Viral Neuroinflammation

Scientists are developing advanced tools to understand and treat neurological symptoms such as brain fog associated with respiratory diseases like influenza. The Biomedical Advanced Research and Development Authority (BARDA), part of the…

USE OUR INTELLIGENCE October 16, 2024
Older Posts Newer Posts
Recent Posts
  • More Young Adults Are Having Strokes Than Three Decades Ago
  • Black Lung Disease Remains a Threat, but Federal Officials Delay Effort To Address It
  • Less Is More: Exercise Rivals Common Pain Meds
  • Study Examines Racial Disparities in Patients’ Adherence to Their Diabetes Medications
  • Two-Thirds of Adults with High Blood Pressure Do Not Know They Have It
Recent Comments
  • johanna blackwell on Tequila Industry Innovator Responds to U.S. Surgeon General’s New Advisory on Link Between Alcohol and Cancer Risk
  • News on Tequila Industry Innovator Responds to U.S. Surgeon General’s New Advisory on Link Between Alcohol and Cancer Risk
  • Bryan GJ on Tequila Industry Innovator Responds to U.S. Surgeon General’s New Advisory on Link Between Alcohol and Cancer Risk
  • Mark Torres on Half the Amount of Chemo Prevents Testicular Cancer from Coming Back, New Trial Shows
  • JD Rowe Financial on Third Wave of Covid-19 Hit Rural America Especially Hard
Archives
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • February 2016
  • November 2015
  • October 2015
Categories
  • DISEASES
  • ENVIRONMENT
  • NEUROLOGY & MENTAL HEALTH
  • PHARMA & CLINICAL TRIALS
  • POLICY & LAW
  • PUBLIC HEALTH
  • RESEARCH
  • TECHNOLOGY
  • Uncategorized
  • VIRUSES & VACCINES
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Tag Cloud
  • TheDailyBrief
  • TheDailyBriefF
  • TheDailyBriefFriday
  • TheDailyBriefMonday
  • TheDailyBriefT
  • TheDailyBriefTH
  • TheDailyBriefW
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

Global Health News Wire
  • HOME
  • GHNW Notes
  • PERMISSIONS AND POLICIES
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

I would like to receive critical industry news to my inbox.

Our site uses cookies. Learn more about our use of cookies: Cookie Policy

ACCEPT